Doctor profile · Federal record
Dr. Mario Bustos Rodriguez, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Tulsa, OK
- NPI 1700265584
- Accepts Medicare
- MIPS 79.4 / 100 · 2023
- 20 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6160 S Yale Ave
Tulsa, OK 741361930
(918) 497-3140
fax (918) 497-2610 - Mailing address
-
6600 S Yale Ave Ste 1400
Tulsa, OK 741363331
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- August 10, 2020
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Oklahoma #35057
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1700265584. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
619
Distinct HCPCS
4
Medicare allowed
$70,895
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 399 | 240 | $119 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 123 | 123 | $158 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 83 | 44 | $33 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 14 | 14 | $85 |
In context: peer comparison
Among 8 peers in Tulsa Endocrinology, Diabetes & Metabolism Physician, average services per provider: 168. This provider delivers 3.7× the peer median.Open Payments
Industry payments received
All-time total
$3,506
Transactions
108
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 16 | $708.25 | |
| Bayer Healthcare Pharmaceuticals INC. | 13 | $411.53 | |
| Amgen INC. | 8 | $337.47 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 8 | $331.91 | |
| Insulet Corporation | 8 | $252.81 | |
| Dexcom, INC. | 16 | $239.84 | |
| Lilly USA, LLC | 12 | $233.03 | |
| Novo Nordisk INC | 9 | $220.08 | |
| Sanofi-Aventis U.S. LLC | 1 | $126.77 | |
| Corcept Therapeutics | 4 | $97.36 | |
| Astellas Pharma US INC | 3 | $77.61 | |
| Tandem Diabetes Care, INC. | 3 | $69.08 | |
| Chiesi USA, INC. | 3 | $59.83 | |
| Xeris Pharmaceuticals, INC. | 2 | $48.30 | |
| Neurocrine Biosciences, INC. | 2 | $46.37 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,723
Patients
823
Total drug cost
$1,765,814
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 424 | 130 | $5,764 |
| Trulicity (Dulaglutide) | Brand | 424 | 87 | $585,963 |
| Metformin Hcl ER (Metformin Hcl) | Brand | 347 | 114 | $3,817 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 234 | 81 | $279,506 |
| Ozempic (Semaglutide) | Brand | 224 | 54 | $272,303 |
| Jardiance (Empagliflozin) | Brand | 196 | 48 | $221,151 |
| Novolog Flexpen (Insulin Aspart) | Brand | 147 | 56 | $120,067 |
| Pioglitazone Hcl | Generic | 125 | 47 | $2,919 |
| Levemir Flexpen (Insulin Detemir) | Brand | 122 | 35 | $104,995 |
| Alendronate Sodium | Generic | 117 | 44 | $1,639 |
Hospital affiliations
Frequently asked questions
What is Dr. Mario Bustos Rodriguez's medical specialty?
Dr. Mario Bustos Rodriguez practices Endocrinology, Diabetes & Metabolism Physician in Tulsa, OK.
Where does Dr. Mario Bustos Rodriguez practice?
Dr. Mario Bustos Rodriguez practices at 6160 S Yale Ave, Tulsa, OK 741361930. Office phone: 9184973140.
What is Dr. Mario Bustos Rodriguez's NPI?
Dr. Mario Bustos Rodriguez's National Provider Identifier (NPI) is 1700265584, issued by NPPES.
Does Dr. Mario Bustos Rodriguez accept Medicare assignment?
Yes. Dr. Mario Bustos Rodriguez accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mario Bustos Rodriguez commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); New patient office or other outpatient visit (HCPCS 99204); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.